PHARMACOKINETICS (PK) OF TIPRANAVIR/RITONAVIR, RIBAVIRIN, PEGYLATED INTERFERON (PEG INF) IN HEPATITIS C (HCV) SUBJECTS WITH MILD HEPATIC IMPAIRMENT AND IN HCV, HEPATITIS B (HBV), HEPATITIS D INFECTED SUBJECTS OR ALCOHOLIC CIRRHOSIS WITH MODERATE HEPATIC IMPAIRMENT: